Ditching Impact Factors for Deeper Data

A team of editors and researchers calls on journal publishers to use citation distributions as measures of publication quality rather than relying on much-derided impact factors.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Science journals should calculate more-detailed citation distributions to indicate the impact of individual studies published in their pages instead of relying on the less-transparent journal impact factor (IF), according to researchers and publishers who analyzed the data underlying these scores. “We hope that this analysis helps to expose the exaggerated value attributed to the JIF [journal impact factor] and strengthens the contention that it is an inappropriate indicator for the evaluation of research or researchers,” wrote the authors of a bioRxiv preprint published this week (July 5).

By calculating simple distribution frequencies for citations of papers published in a variety of journals, the team—which included 11 top journal editors from eLife, Science, Nature, PLOS, and others—found that up to 75 percent of the studies in a given journal had lower citation counts than that journal’s IF, which indicates the average number of citations an article in that title nets. “The authors are correct to point out that JIF should only be used as an aid to understand the impact of a journal,” James Pringle, head of industry development and innovation, IP and science at Thomson Reuters, which calculates journal IFs, told ScienceInsider. “JIF is a reflection of the citation performance of a journal as a whole unit, not as an assembly of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies